ACTRN12605000774628终止不适用
A placebo controlled cross-over pilot investigation of the efficacy of Botulinum toxin Type A (Dysportÿ®) as an adjunct to the non-surgical treatment of chronic lateral epicondylitis.
Dr BJ Singer, School of Surgery and Pathology, The University of Western AustraliaMedical Research Foundation Building, Level 2, Rear 50 Murray Street, Perth, WA 60000 个研究点目标入组 24 人开始时间: 2005年12月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- ot stated 至 ot stated（—）
- 性别
- All
入选标准
- •Diagnosis of 'tennis elbow' (pain over lateral epicondyle, increased by forceful gripping, resisted wrist extension- Symptoms for >6 months duration, not responded to conservative management (physiotherapy, bracing, splinting, steroid injection)- Males and non pregnant females.
排除标准
- •Previous BTXA injection within 3 months or any history of adverse reaction to BTXA- Disorders producing disturbed neuromuscular transmission (eg: myasthenia gravis)- Concurrent use of aminoglycosides [potential sensitiser to effect of BTXA]- Active Rheumatoid arthritis involving the upper extremity - Previous elbow surgery or nerve entrapment of the affected extremity- Workers Compensation or other compensable patients.
研究者
相似试验
已完成
不适用
Cross-over randomized placebo-controlled pilot study to determine the effect in healthy elderly volunteers of the anti-ageing supplement *Promanna** on a number of biomarkers associated with DNA-damage and oxidative stress (PromAge)iet van toepassing, het gaat om gezonde vrijwilligers.NA (this is about healthy ageing)NL-OMON40413niversitair Medisch Centrum Groningen20
已完成
不适用
The effect of dairy-derived proteins on circulating lipids and related cardiovascular risk factors in mildly hypercholesterolaemic individualsACTRN12611001013954actoPharma25
进行中（未招募）
1 期
A Randomized, Placebo-Controlled Study to Evaluate the Effect of Amifampridine in Patients with MuSK Antibody Positive Myasthenia GravisPatients with MuSK Antibody Positive Myasthenia GravisMedDRA version: 19.1Level: LLTClassification code 10062976Term: Neuromuscular weaknessSystem Organ Class: 100000004859EUCTR2015-003127-62-ITFONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA20
进行中（未招募）
1 期
A study to explore the benefits of AUT00063 in adults receiving Cochlear ImplantEUCTR2015-003929-34-GBAutifony Therapeutics Limited15
已完成
2 期
Study A: A placebo-controlled crossover study to assess safety of intranasal administration of palivizumab Study B: Effect of intranasal administration of palivizumab on respiratory syncytial virus-associated infection - a double-blind randomized controlled trialbronchiolitisNL-OMON55390niversitair Medisch Centrum Utrecht408